Volume 20 - Issue 10 - October, 2008

Editor’s Message

Dear Readers,

This issue of the Journal of Invasive Cardiology continues our series of special focus sections to provide a more in-depth examination of important topics in cardiovascular medicine. The special section for the October 2008 issue includes articles focusing on the use of radial artery access for diagnostic and interventional catheterization procedures. The guest editor for this section is Dr. Deepak Bhatt, Chief of Cardiology at the VA Boston Healthcare system and director of the Integrated Interventional Cardiology Program at the VA and the Brigham and Women&rsquo...

Percutaneous Mitral Valvuloplasty through a Carpentier-Edwards Ring

*M. Kettani, MD,  §Belghiti Hasnaa, MD,  *N. El Haitem, PhD

Author Affiliations:

From the *Department of Cardiology A, University Hospital Ibn Sina, Rabat, Morocco, and the §Department of Cardiology B, University Hospital Ibn Sina, Rabat, Morocco.

The authors report no conflicts of interest regarding the content herein.

Manuscript submitted February 5, 2008, provisional acceptance given February 20, 2008, manuscript accepted March 3, 2008.

Address for correspondence: Belghiti Hasnaa, MD, Department of Cardiology B, University Hospital Ibn Sina, Rabat, Morocco. E-mail: [email protected]

...

Three Cases of Left Main Stem Thrombus Complicating PCI: The Role of FilterWire Protection for the Virgin Territory

Eugene B. Wu, MRCP, MD,  Wilson W.M. Chan, FRCP,  Cheuk-Man Yu, MD

Author Affiliations:

Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University Hong Kong.

There are no grants, financial support, or conflicts of interests related to the research in this paper.

Manuscript submitted February 14, 2008, provisional acceptance given April 28, 2008, manuscript accepted June 3, 2008.

Address for correspondence: Eugene Brian Wu, MRCP, MD, Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University Hong Kong, Ngan Shing Street, Shatin, Hong Ko...

Covered Stent for the Treatment of Recurrent Bilateral Renal Artery In-Stent Restenosis

*,§Bryan P. Yan, MBBS, FRACP,  §Thomas J. Kiernan, MD, MRCPI,  §Kenneth Rosenfield, MD

Author Affiliations:

From the Cardiology Division, Section of Vascular Medicine, Massachusetts General Hospital and §Harvard Medical School, Boston, Massachusetts.

Disclosures: Dr. Rosenfield has received research grants from Idev, Abbott Vascular, Cordis Corp., Boston Scientific Corp., Bard, Baxter, Invatec, and Lumen; is a consultant to Cordis, Boston Scientific, Baxter, CardioMind, Micelle, Complete Conference Management, Idev, Abbott Vascular, Boston Biomedical Associates; owns stock in Lumen, CardioMind, Xtent, and Cardiomems; and has a financial relationship with VIVA...

Late Outcomes after Drug-Eluting Stent Implantation in “Real-World” Clinical Practice

David R. Ramsdale, MB, ChB, FRCP, MD, Archana Rao, MB, ChB, MRCP, MD, Omar Asghar, MB, ChB, MRCP,
Kathryn A. Ramsdale, BSc, MB, ChB, Ewan McKay, BSc, MB, ChB<p></p>

Author Affiliations:  From the Cardiothoracic Centre, Liverpool, United Kingdom.
The authors report no conflicts of interest regarding the content herein.
Manuscript submitted March 24, 2008, provisional acceptance given April 30, 2008, manuscript accepted July 21, 2008.
Address for correspondence: Dr. David R Ramsdale, Consultant Cardiologist, The Cardiothoracic Centre, Thomas Drive, Liverpool. L14 3PE. Email: [email protected]
 

ABSTRACT: Background. We report the late outcomes in 411 consecutive patients undergoing drug-eluting stent (DES) implantation by a single operator between 2003–2006. Methods. Prospective registry with continuous follow up. Patients with stable angina (SA) or acute coronary syndrome (ACS) received DES for long lesions, small vessels, chronic total occlusion, bifurcation, aorto-ostial, left main, post atherectomy or saphenous vein graft lesions, multivessel/multilesion single vessel (V) disease, in-stent restenosis (ISR) or diabetes. Results. Age range: 34–86 yea...

Percutaneous Repair of a Pseudoaneurysm Associated with Coarctation of the Aorta

Wael F. Al-Husami , MD and Thomas Piemonte, MD

Author Affiliations:

From the Department of Cardiology, Lahey Clinic Medical Center, Tufts University School of Medicine, Burlington, Massachusetts.

Disclosure: Dr. Piemonte is a member of the speaker’s bureau for Boston Scientific Corporation.

Manuscript submitted March 10, 2008, provisional acceptance given June 3, 2008, manuscript accepted June 11, 2008.

Address for correspondence: Wael F. Al-Husami, MD, Department of Cardiology, Lahey Clinic Medical Center, Tufts University School of Medicine, 41 Mall Road, Burlington, MA 01805. E-mail: [email protected]...

Outcomes of DES in Real World Practice: Realizing the Potential

1Pranab Das, MD, 2Vikramjit Chokar, MD, 3Aravinda Nanjundappa, MD, RVT, 4Robert S. Dieter, MD, RVT

Author Affiliations: 

From the 1Division of Cardiovascular Medicine, University of Tennessee Health Sciences Center, Memphis, Tennessee, 2University of Wisconsin-Madison, Wisconsin, 3Department of Medicine and Surgery, West Virginia University, Charleston, West Virginia, and 4Department of Interventional Cardiology, Loyola University, Maywood, Illinois,
The authors report no conflicts of interest related to the content herein.
Address for correspondence: Pranab Das, MD, Assistant Professor, Division of Cardiovascular Medicine, University of Tennessee Health Sciences Center, Memphis, TN 38163. Email: [email protected]
 

Since the approval of the drug-eluting stents (DES) in April of 2003 by the U.S. Food and Drug Administration (FDA) and a year earlier in Europe, the rise of DES had been phenomenal, a feat rarely seen in contemporary medicine. With much lower in-stent restenosis compared to their bare metal counterparts, use of DES in interventional cardiology immediately become the default choice in the cardiac catheterization laboratory. The randomized trials that led to the approval of both initial DES [sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES)] were applicable to a highly selec...

Spontaneous Hemopericardium in a Patient with Hemophilia B: A Case Report and Review of the Literature

Dee Dee Wang, MD,  Christos Kasapis, MD,  Brahmajee K. Nallamothu, MD, MPH

Author Affiliations:

From the University of Michigan Health System, Ann Arbor, Michigan.
The authors report that there are no disclosures or conflicts of interest relevant to this publication.
Manuscript submitted March 3, 2008, provisional acceptance given April 22, 2008, manuscript accepted June 30, 2008.
Address for Correspondence: Dee Dee Wang, MD, University of Michigan Health System,3116G TC SPC 5368, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5368. E-mail: [email protected]

_______________________________________________

...

Coronary Stenting with MGuard: First-In-Man Trial

§Edo Kaluski, MD, £Karl Eugen Hauptmann, MD, *Ralf Müller, MD, §Steve Tsai, MD,
§Marc Klapholz MD, *Eberhard Grube, MD

Author Affiliations: 
From the *Department of Cardiology, Helios Heart Center, Siegburg, Germany, the  §Department of Cardiology, University Medical Center and the University of Medicine and Dentistry, Newark, New Jersey; and the £Department of Cardiology Krankenhaus der Barmherzigen Brüder Trier, Germany 
Disclosures: Dr. Kaluski is a consultant to and stockholder in Inspire-MD. Professor Grube is a consultant to Inspire-MD.
Manuscript submitted February 22, 2008, provisional acceptance given May 12, 2008, manuscript accepted June 30, 2008.
Address for correspondence: Edo Kaluski MD, FACC, FESC, Director of Invasive Cardiology and Cardiac Catheterization Laboratories, University Hospital, University of Medicine and Dentistry of New Jersey, 185 South Orange Avenue, MSB I-538, Newark, NJ   07101.  E-mail: [email protected]

ABSTRACT: MGuard is a bare-metal stent covered by an ultra-thin polymer mesh sleeve on its external surface, designed to reduce embolization during coronary, cerebrovascular and peripheral interventions. Aim. To evaluate the feasibility and safety of MGuard-based percutaneous coronary interventions (PCIs) of human native coronary arteries (NCs) and coronary vein grafts (VGs). Methods. MGuard-based PCI executed by 2 centers with postprocedural clinical and laboratory monitoring; including creatinine phosphokinase (CPK), troponin, electrocardiography and 6-month angiographic ...

An Uncommon Complication after a Common Procedure

Ravi S. Math, DM,  Sandeep Singh, DM,  Vinay Bahl, DM

Author Affiliations:

From All India Institute of Medical Sciences, New Delhi, India.
The authors report no conflicts of interest regarding the content herein.

Manuscript submitted April 23, 2008 and accepted May 19, 2008.

Address for correspondence: Ravi S. Math, MBBS, MD, DM, All India Institute of Medical Sciences, Department of Cardiology, Ansari Nagar, New Delhi, Delhi 110029 India. E-mail: [email protected]

_______________________________________________

ABSTRACT: A 50-year-old female developed cortical b...

Editorial Staff
  • Executive Officer
    Laurie Gustafson
  • Production
    Elizabeth Vasil
  • National Account Manager
    Jeff Benson
  • Senior Account Director
    Carson McGarrity
  • Special Projects Editor
    Amanda Wright
Editorial Correspondence
Back to top